RU2001126943A - A method for predicting the development of retinopathy of prematurity - Google Patents

A method for predicting the development of retinopathy of prematurity

Info

Publication number
RU2001126943A
RU2001126943A RU2001126943/14A RU2001126943A RU2001126943A RU 2001126943 A RU2001126943 A RU 2001126943A RU 2001126943/14 A RU2001126943/14 A RU 2001126943/14A RU 2001126943 A RU2001126943 A RU 2001126943A RU 2001126943 A RU2001126943 A RU 2001126943A
Authority
RU
Russia
Prior art keywords
retinopathy
development
predicting
prematurity
premature infants
Prior art date
Application number
RU2001126943/14A
Other languages
Russian (ru)
Other versions
RU2216740C2 (en
Inventor
Людмила Анатольевна Катаргина
Ольга Семеновна Слепова
Петр Петрович Скрипец
Галина Михайловна Дементьева
Григорий Рафаэлович Каламкаров
Original Assignee
Московский научно-исследовательский институт им. Гельмгольца
Filing date
Publication date
Application filed by Московский научно-исследовательский институт им. Гельмгольца filed Critical Московский научно-исследовательский институт им. Гельмгольца
Priority to RU2001126943/14A priority Critical patent/RU2216740C2/en
Priority claimed from RU2001126943/14A external-priority patent/RU2216740C2/en
Publication of RU2001126943A publication Critical patent/RU2001126943A/en
Application granted granted Critical
Publication of RU2216740C2 publication Critical patent/RU2216740C2/en

Links

Claims (1)

Способ прогнозирования развития ретинопатии недоношенных, включающий иммунологическое исследование сыворотки крови, отличающийся тем, что определяют наличие антител класса Ig G и Ig M к S-антигену сетчатки методом иммуно-ферментного анализа и при показателях относительной плотности >0,1 каждого из них в сроки 29-40 недель гестации прогнозируют развитие ретинопатии недоношенных.A method for predicting the development of retinopathy of premature infants, including an immunological study of blood serum, characterized in that the presence of antibodies of class Ig G and Ig M to the retinal S antigen is determined by enzyme-linked immunosorbent assay and with relative density indices> 0.1 of each of them in terms of 29 -40 weeks of gestation predict the development of retinopathy of premature infants.
RU2001126943/14A 2001-10-05 2001-10-05 Method for predicting development of retinopathy in premature babies RU2216740C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2001126943/14A RU2216740C2 (en) 2001-10-05 2001-10-05 Method for predicting development of retinopathy in premature babies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2001126943/14A RU2216740C2 (en) 2001-10-05 2001-10-05 Method for predicting development of retinopathy in premature babies

Publications (2)

Publication Number Publication Date
RU2001126943A true RU2001126943A (en) 2003-07-10
RU2216740C2 RU2216740C2 (en) 2003-11-20

Family

ID=32026912

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001126943/14A RU2216740C2 (en) 2001-10-05 2001-10-05 Method for predicting development of retinopathy in premature babies

Country Status (1)

Country Link
RU (1) RU2216740C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2618395C1 (en) * 2016-03-24 2017-05-03 Государственное бюджетное учреждение "Уфимский научно-исследовательский институт глазных болезней Академии наук Республики Башкортостан" Prediction method of premature retinopathy active phase development
RU2751007C1 (en) * 2020-12-02 2021-07-07 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр глазных болезней имени Гельмгольца" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ГБ им. Гельмгольца" Минздрава России) Method for predicting the development of extraretinal vasoproliferation in experimental retinopathy of prematurity (rop)

Similar Documents

Publication Publication Date Title
ATE368221T1 (en) IMMUNOASSAYS FOR ANTI-HCV ANTIBODIES
DE60130852D1 (en) Immunoassay for measuring the human C-peptide and reagent kit therefor
EA200500643A1 (en) METHOD OF UNCONCURENT IMMUNO ANALYSIS TO DETERMINE SMALL ANALYTES
DE60116172D1 (en) Immunoassay for C-reactive protein
NO992472L (en) Method for diagnosing metabolic bone disorders
EP1072888A3 (en) Immunoassay method and reagent for HIV-1p24 antigen
KR850002385A (en) Method and reagent for measuring PIVKA-II
PT902286E (en) IMMUNOSIS USING TWO INCUBATIONS WITH ANTIGENS MARKED
RU2001126943A (en) A method for predicting the development of retinopathy of prematurity
FR2778744B1 (en) IMMUNOLOGICAL ASSAY FOR HUMAN CHROMOGRANIN (CGA) ANTIBODIES, REAGENTS AND KITS FOR USE IN THIS ASSAY
BR0314166A (en) Hcv test
EP0245052A3 (en) Detection of inflammation and novel antibodies therefor
ES2131279T3 (en) SANDWICH TYPE IMMUNO ASSAY FOR N-PEPTIDE.
DE60138958D1 (en) NEURO TRANSMISSION PROBLEMS
Jones et al. Fluorescent enzyme immunoassay for antibody to single-or double-stranded DNA
FI904304A0 (en) FOERFARANDE FOER PAOVISANDE AV ANALYTER.
Guohua et al. Preparation and testing of hepatitis C core antigen ELISA reagent
JP2004191382A5 (en)
EP1202064A3 (en) Method for detecting antibodies to and antigens of fungal and yeast exposures
ATE408830T1 (en) METHOD AND ANTIBODIES FOR DETECTING ALCOHOL CONSUMPTION
Notermans et al. In vitro techniques for detecting botulinal toxins.
RU2002115475A (en) Enzyme-linked immunosorbent assay for determining the soluble form of HLA-DR antigens in human serum
BR9102727A (en) PROCESS FOR THE PREPARATION OF A MONOCLONAL ANTIBODY, MONOCLONAL ANTIBODIES, CELL LINE, PROCESS FOR THEIR PREPARATION, PROCESS FOR THE IMMUNOLOGICAL DETERMINATION OF SULPHONYLUREA HERBICIDES, AGENT FOR DETERMINING THE IMMUNOLOGICAL COMPONENT AND COMPONENT OF IMMUNOLOGICAL COMPONENT FOR COMPONENT, IMMUNOLOGICAL COMPONENTS
RU97111288A (en) METHOD FOR SEROLOGICAL DIAGNOSTICS OF TUBERCULOSIS IN PATIENTS WITH IMMUNO DEFICIENCY
RU2001102987A (en) METHOD FOR DIAGNOSTIC OF CHRONIC ALCOHOL INTOXICATION